London, United Kingdom, January 16, 2022 –(PR.com)– Only four weeks to go until the 5th Annual 3D Cell Culture will now take place as a ‘Virtual Conference’ with online access only on 9th and 10th February 2022.

Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.

3D Cell Culture technology promises to offer increased translatability in models and reduce the costly rates of drug attrition in the discovery process — heralding the next major advance in the discovery of pharmaceuticals.

Interested parties can register for the virtual conference at www.3D-cellculture.com/PR3.

SMi Group are delighted to welcome new speakers from leading pharmaceutical companies; Abbvie, GSK, Scripps Research and Engitix Therapeutics who are…